Explore how human-relevant tumor models like 3D cultures, organoids, organ-on-chip platforms, and the 3MIC system are ...
Early-stage cancer immunotherapy represents a promising yet underexplored frontier in cancer research. While immunotherapeutic strategies have achieved ...
A team of scientists at Henry Ford Health + Michigan State University Health Sciences have uncovered a mechanism that allows ...
Recent advancements in cancer vaccine development have demonstrated their potential for precise tumor targeting through antigen-specific immune activation. Nevertheless, critical challenges persist in ...
Preclinical data demonstrates leronlimab-mediated CCR5 inhibition enhances Temozolomide and radiation response in Glioblastoma Leronlimab ...
Researchers have engineered a dual-targeting nanocarrier that safely sneaks potent chemotherapy past the blood-brain barrier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results